Registered entities
Glaukos Corporation
Reg. No. 330945406United States
Glaukos Corp
Reg. No. 1192448United States
Glaukos Corporation
Reg. No. 0683.833.568Belgium
Innovation
78 patent families (57 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 61,513 times.
| Year | Filings |
|---|---|
| 2015 | 12 |
| 2016 | 12 |
| 2017 | 14 |
| 2018 | 16 |
| 2019 | 23 |
| 2020 | 18 |
| 2021 | 19 |
| 2022 | 17 |
| 2023 | 20 |
| 2024 | 16 |
| 2025 | 23 |
| 2026 | 15 |
Social engagement
Social engagement: 37.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Meritech; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 64% |
| Private equity | 3 | 27% |
| Other / undisclosed | 1 | 9% |
Hiring activity
Hires periodically
6 roles tracked across 4 of the last 12 months
31 Mar 2026 · Director, Payer Relations · St. Louis
31 Mar 2026 · Interventional Business Manager · Fort Lauderdale
10 Feb 2026 · Clinical Research Director · Aliso Viejo
6 Feb 2026 · Medical Science Liaison · Miami
11 Nov 2025 · Reimbursement Liaison · Kansas City
Based on job postings tracked across public sources.
Recent activity
10 Apr 2026
Event
ASCRS